Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$16.62 - $18.94 $91,410 - $104,170
-5,500 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$16.86 - $19.67 $92,730 - $108,185
5,500 New
5,500 $101,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.9B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Grant Street Asset Management, Inc. Portfolio

Follow Grant Street Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant Street Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grant Street Asset Management, Inc. with notifications on news.